- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/81 - Inhibiteurs de protéase
Détention brevets de la classe C07K 14/81
Brevets de cette classe: 1203
Historique des publications depuis 10 ans
|
101
|
81
|
86
|
103
|
113
|
93
|
84
|
88
|
58
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1126 |
35 |
| Angiochem Inc. | 40 |
24 |
| Translate bio, Inc. | 415 |
19 |
| The Regents of the University of California | 20778 |
18 |
| Avacta Life Sciences Limited | 36 |
18 |
| Daiichi Sankyo Company, Limited | 1890 |
18 |
| Takeda Pharmaceutical Company Limited | 2710 |
16 |
| Cytonics Corporation | 24 |
15 |
| Sanofi Aatd Inc. | 17 |
15 |
| Serpin Pharma, LLC | 23 |
14 |
| CSL Behring GmbH | 346 |
13 |
| Biotissue Holdings Inc. | 80 |
12 |
| Genentech, Inc. | 4110 |
11 |
| ProThera Biologics, Inc. | 23 |
11 |
| Omeros Corporation | 306 |
9 |
| Azitra, Inc. | 43 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6656 |
8 |
| 3B Pharmaceuticals GmbH | 52 |
8 |
| University of Massachusetts | 2317 |
8 |
| Clara Foods Co., AKA Clara Foods | 104 |
8 |
| Autres propriétaires | 914 |